Navigation Links
Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
Date:9/21/2010

TORONTO, Sept. 21 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the introduction and adoption of new growth factors, combined with greater variety and improved features of newer products, will drive the US bone graft substitute market to nearly $2.3 billion through 2015.

Medtronic Spinal & Biologics' new bone morphogenetic protein, AMPLIFY, is set to be released in the US market in 2011. Unlike INFUSE, however, AMPLIFY is combined with a collagen and ceramic matrix designed for implantation in single-level posterolateral lumbar fusions—an indication that current bone morphogenetic proteins do not have approval for. BioMimetic Therapeutics' Augment Bone Graft is also set to enter the US market in 2011. The device's platelet-derived growth factor is touted by BioMimetic Therapeutics for having five times the rate of chemotaxis (the ability to recruit stem cells) and the ability to stimulate the replication of osteoblasts, not normally typical of bone morphogenetic proteins.

Orthopedic stem cell products, such as NuVasive's Osteocel Plus, Orthofix's Trinity Evolution, or AlloSource's AlloStem, contain stem cells that can differentiate into a variety of tissue cells to promote bone healing. Such products offer superior effectiveness compared with many alternative substitutes. Second-generation synthetic products, such as Orthovita's Vitoss BA and Baxter's Actifuse have integrated bioactive components that increase osteoinductivity and thus accelerate bone growth and healing. The improved features of these products will promote surgeon adoption of these materials over autografts, while their higher prices compared to older generation products will contribute to revenue growth over the next five years.

"Surgeons certainly have a plethora of choice when it comes to bone graft substitutes," says Deanna Vankessel, Senior Analyst at MRG. "The increased marketing that will follow the pending approval of AMPLIFY and Augment will contribute to even greater awareness of all of the viable alternatives to the conventional, yet gold-standard, autograft harvesting technique."

MRG's US Markets for Orthopedic Biomaterials 2010 report provides critical insight into emerging trends that will fuel product adoption and market growth for bone graft substitutes, hyaluronic acid viscosupplementation, machined bone interbody devices, cell concentration systems, and knee cartilage repair treatments in the US through 2015. Additionally, the report provides a complete breakdown of procedure volumes, unit sales, average selling prices, and revenues by device type. This report includes five-year forecasts, up-to-date market shares, and in-depth qualitative insights.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Amy KrohnMillennium Research Group416-364-7776 ext. 101akrohn@mrg.netChris Comfort
Decision Resources Inc.
781-993-2597
ccomfort@dresources.com
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ConvaTec Expands AQUACEL® Dressing Product Line With Introduction of New Ribbon Dressing
2. Halozyme Provides HYLENEX® Product Reintroduction Update
3. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
4. RegenceRx Leads the Industry With Introduction of Medication Cost Integration
5. Bioniche Pharma and Academic Pharmaceuticals, Inc. Announce the Introduction of Sotalol Hydrochloride Injection
6. Using Internal Communications to Help Build a Credible External Message Regarding New Pharmaceutical Products
7. Waters Introduces Ostro Sample Preparation Products
8. Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008
9. Magic-Seal Packaging Products to Introduce First Vytex® Natural Rubber Latex Napkin Rings
10. Henry Schein Provides Health Care Products for Relief After Flooding in Pakistan
11. Frost & Sullivan Applauds the Lodox Statscan Critical Imaging System for Outperforming All Competing Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... NORWALK, Conn. , April 27, 2016 /PRNewswire/ ... availability of its digital health technology platform, which ... services and programs into scalable digital products, Zillion ... mobile engagement and empower consumers to take control ... features face-to-face live video conferencing – including one-to-one, ...
(Date:4/27/2016)... April 27, 2016 Shire plc (LSE: ... Poulton , Chief Financial Officer, will present at the Deutsche ... MA on Wednesday, May 04, 2016, 10:00 am ... be available on the Presentations and Webcasts section of Shire,s ... the webcast will be available on this same website for ...
(Date:4/27/2016)... April 27, 2016 Global  ... 2.14 billion by 2022, according to a new ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... the efficiency and accuracy delivered by the new ... for novel urinalysis instruments and consumables. For instance, ...
Breaking Medicine Technology:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... feature Grassland Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 ... century of churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin ...
(Date:4/29/2016)... ... April 29, 2016 , ... Nike Softball Camp at the College of ... – 27th for girls aged 10-18. All facets of the game will be covered; ... V. Whited Complex, one of the finest softball facilities in the region. The outstanding ...
(Date:4/29/2016)... ... , ... Coalition Duchenne, a Newport Beach, California based charity ... participated in the April 25 U.S. Food and Drug Administration advisory committee hearing ... at the Marriott Conference Center in Hyattsville, Maryland was attended by over than ...
(Date:4/29/2016)... ... April 29, 2016 , ... Pro3rd Grunge is a package of ... lower thirds to introduce people, characters, and locations without having to set a single ... textures and many more design components. Simply select a preset and drag it into ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... recently announced that their founders, Dr. Gemmi and Dr. Middleberg, were asked by ... orthodontists around the nation. During the seminar, titled “Advancing the Biomechanics of ...
Breaking Medicine News(10 mins):